课题基金 / 基金详情

Protective T cell responses to Chlamydial Infection

Protective T cell responses to Chlamydial Infection
T 细胞对衣原体感染的保护性反应
批准号:
8379413
负责人:
Thomas L. Cherpes
金额:
$45.11万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Thomas L. Cherpes的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pelvic inflammatory disease (PID) is defined as an infection of the endometrium, fallopian tubes, and adjacent structures that is caused by the ascension of microorganisms from the lower to upper genital tract The microorganism most convincingly associated with PID is Chlamydia trachomatis, and our proposal would provide the exciting opportinity for a discovery of the antigen-specific cell mediated immune resposes that are most strongly associated with protection against C. trachomatis infection as well as the elucidation of the antigen specifc immune responses correlated with containment of C. trachomatis infection to the lower genital tract. The 200 women enrolled into this longitudinal investigation will be recruited from an acute PID cohort (Project 1) and from a cohort of women who are at high risk for endocervical infection with C. trachomatis (Project 4). Completion of our investigation will allow: 1. Better understanding of the CD4 T cell antigen-specific responses that are most strongly associated with protection from C. trachomatis infection at enrollment. 2. Better elucidation of the CD4 T cell antigen-specific responses that are most strongly correlated with protection from incident C. trachomatis infection. 3. Identification of novel chlamydia-specific T cell responses that are most strongly associated with the decreased likelihood of ascension of C. trachomatis from the lower to upper genital tract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a nonsteroidal and nonhormonal agent that reverses menopause-related loss of genital epithelial integrity and function
  • 批准号:
    10901049
  • 项目类别:
  • 资助金额:
    $39.11万
  • 财政年份:
    2023
  • 负责人:
    Thomas L. Cherpes
  • 依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
  • 批准号:
    10024512
  • 项目类别:
  • 资助金额:
    $41.05万
  • 财政年份:
    2018
  • 负责人:
    Thomas L. Cherpes
  • 依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
  • 批准号:
    10412065
  • 项目类别:
  • 资助金额:
    $75.07万
  • 财政年份:
    2018
  • 负责人:
    Thomas L. Cherpes
  • 依托单位:
Estrogen reverses progestin-mediated loss of genital mucosal barrier function
  • 批准号:
    10172944
  • 项目类别:
  • 资助金额:
    $6.94万
  • 财政年份:
    2018
  • 负责人:
    Thomas L. Cherpes
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究